Clinical trial

A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension

NCT00788541

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2008-12-01

PhasePHASE2

Study timeline

Study start (unknown)2008-12-01Date precision: month

Registry last updated2012-11-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Open-Angle Glaucomaunresolved

Ocular Hypertensionunresolved

Interventions

Anecortave Acetate Sterile Suspension, 6 mg/mLDRUG

Anecortave Acetate Sterile Suspension, 3.75 mg/mLDRUG

Anecortave Acetate Sterile Suspension, 96 mg/mLDRUG

Anecortave Acetate Sterile Suspension, 60 mg/MLDRUG

Anecortave Acetate VehicleOTHER

Sponsors & collaborators

Alcon Researchlead sponsor

Mapped research locations

Fort WorthTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00788541 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.